Total planned funding: $276,813,263
Clear active filters
John Snow, Inc
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $102,605,448 |
Uganda | $73,970,423 |
Nigeria | $17,551,630 |
South Africa | $12,991,442 |
Ethiopia | $9,858,377 |
Haiti | $6,239,151 |
Tanzania | $6,164,749 |
Mozambique | $5,114,346 |
Malawi | $5,080,895 |
Dominican Republic | $4,943,501 |
West Africa Region | $4,015,397 |
Guyana | $3,600,000 |
Rwanda | $3,561,993 |
Côte d'Ivoire | $3,462,646 |
Kenya | $3,192,610 |
Ghana | $3,137,508 |
Botswana | $2,924,747 |
Caribbean Region | $2,115,000 |
Zimbabwe | $1,840,000 |
Eswatini | $1,250,000 |
Lesotho | $980,000 |
India | $900,000 |
Namibia | $563,400 |
Indonesia | $400,000 |
Central America Region | $350,000 |
Central Asia Region | $0 |
South Sudan | $0 |
Ukraine | $0 |
Organizational Types
Private Contractor | $254,399,738 |
Implementing Agency | $16,236,514 |
NGO | $6,177,011 |
Program Areas
Prevention | $94,366,238 |
Governance and Systems | $62,050,301 |
Treatment | $54,001,760 |
Care | $46,943,255 |
Testing | $19,451,709 |
Budget Codes
OHSS: Health Systems Strengthening | $38,782,786 |
HMIN: Biomedical Prevention: Injection Safety | $38,166,637 |
HTXS: Treatment: Adult Treatment | $37,787,865 |
HBHC: Care: Adult Care and Support | $23,950,358 |
HVSI: Strategic Information | $19,856,712 |
HVCT: Testing: HIV Testing and Counseling | $19,451,709 |
HVOP: Sexual Prevention: Other Sexual Prevention | $16,834,179 |
HKID: Care: Orphans and Vulnerable Children | $14,967,454 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,613,794 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $13,729,028 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,022,600 |
HTXD: Treatment: ARV Drugs | $9,790,000 |
PDTX: Treatment: Pediatric Treatment | $6,423,895 |
HVTB: Care: TB/HIV | $4,408,704 |
PDCS: Care: Pediatric Care and Support | $3,616,739 |
HLAB: Laboratory Infrastructure | $3,410,803 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
John Snow, Inc:
$276,813,263
View countries